Drug Pricing Pressure in India: India’s Supreme Court questioned steep hospital mark-ups on cancer medicines, calling it “carnage” after a drug supplied at Rs 2,700 carried an MRP of Rs 27,000, and asked whether a uniform 16% margin should apply. Global Pharma Supply Strain: Iran faces soaring medicine prices—some tripling—as US blockade and sanctions disrupt imports, with pharmacy access getting harder even if hospitals haven’t yet seen major shortages. Oncology Pipeline Roundup: FDA oncology activity in September 2026 included accelerated approvals for camizestrant in ESR1-mutant breast cancer and sevabertinib in treatment-naive HER2-mutant NSCLC, plus multiple other approvals and one withdrawal. Myeloma Treatment Evolution: New expert discussions highlight how CD38-directed therapy is moving into frontline care and how clinicians are weighing bispecific antibodies versus BCMA CAR T-cell therapy, including infection and neurologic risk management. Healthcare Operations & Tech: Cold Chain Technologies launched a reusable dry ice shipper aimed at protecting ultra-low temperature shipments; drones are also being tested to speed AED delivery for out-of-hospital cardiac arrest. Workforce & Community: Parkview Health earned a Forbes/Statista workplace honor; local health groups and hospitals also announced community events and grants, including cardiac monitors via FEMA funding.